Phase I/II trial of DPX 0907 cancer vaccine in patients with breast and ovarian cancers

Trial Profile

Phase I/II trial of DPX 0907 cancer vaccine in patients with breast and ovarian cancers

Withdrawn prior to enrolment
Phase of Trial: Phase I/II

Latest Information Update: 20 Apr 2015

At a glance

  • Drugs DPX 0907 (Primary)
  • Indications Breast cancer; Ovarian cancer
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 20 Apr 2015 Status changed from planning to withdrawn prior to enrolment, according to an Immunovaccine media release.
    • 20 Apr 2015 According to an Immunovaccine media release, this trial will no longer proceed due to unforeseen extended delays at the clinical site.
    • 04 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top